XSpray Pharma AB

NEW
OSTO:XSPRAY (Sweden)  
kr 16.88 +0.24 (+1.44%) Jul 31
At Loss
P/B:
1.23
Market Cap:
kr 800.39M ($ 83.94M)
Enterprise V:
kr 827.52M ($ 86.79M)
Volume:
26.36K
Avg Vol (2M):
167.14K
Trade In:
Volume:
26.36K
At Loss
Avg Vol (2M):
167.14K

GF Valueâ„¢

XSpray Pharma AB’s share price is kr16.88. Its GF Value is kr0. Based on the relationship between the current stock price and the GF Value, GuruFocus believes XSpray Pharma AB stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: kr16.88 GF Value Price/GF Value
Current kr0 Infinity
Next FY1 End kr0 Infinity
Next 12 Month kr0 Infinity
Next FY2 End kr0 Infinity
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing XSpray Pharma AB's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The analysis reveals the strongest correlation between XSpray Pharma AB's stock price and Earnings without NRI per share, with a coefficient of 66%. This is followed by a 62% correlation with Book Value per share. XSpray Pharma AB’s stock price shows no significant correlation with Operating Cash Flow per share. XSpray Pharma AB’s stock price shows no significant correlation with Revenue per share.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies